Holen Sie sich die Stockscreener-App
95.73
0.12%
-0.115
Vorhandelsmarkt:
96.11
0.375
+0.39%
Biontech Se Adr Aktie (BNTX) Neueste Nachrichten
First Trust Advisors LP Has $35.28 Million Holdings in BioNTech SE Sponsored ADR $BNTX - Defense World
BioNTech: Maintaining "Strong Buy" After Part 1 Success Of Next-Gen Anti-CTLA-4 Gotistobart - Seeking Alpha
BioNTech-Bristol Drug Shows Hope For Breast Cancer Patients With Few Options - Benzinga
DoorDash Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
BioNTech stock rises after promising lung cancer drug shows survival benefit By Investing.com - Investing.com South Africa
BioNTech stock rises after promising lung cancer drug shows survival benefit - Investing.com
Dodge & Cox Invests $93.42 Million in BioNTech SE Sponsored ADR $BNTX - MarketBeat
BioNTech’s (BNTX) “Buy” Rating Reaffirmed at Jefferies Financial Group - Defense World
Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules - Yahoo Finance
Scotia Capital Inc. Cuts Stock Position in BioNTech SE Sponsored ADR $BNTX - MarketBeat
Validea's Top Health Care Stocks Based On Benjamin Graham12/1/2025 - Nasdaq
Groupama Asset Managment Buys 26,681 Shares of BioNTech SE Sponsored ADR $BNTX - MarketBeat
Employees Retirement System of Texas Has $1.69 Million Position in BioNTech SE Sponsored ADR $BNTX - MarketBeat
Legal & General Group Plc Boosts Stock Position in BioNTech SE Sponsored ADR $BNTX - MarketBeat
Aristides Capital LLC Purchases 2,826 Shares of BioNTech SE Sponsored ADR $BNTX - MarketBeat
BioNTech SE ADR Rises 3.0%, Outperforms Market - 富途牛牛
Edmond DE Rothschild Holding S.A. Raises Stock Position in BioNTech SE Sponsored ADR $BNTX - MarketBeat
BioNTech’s acquisition of CureVac nears completion as offer deadline approaches - Investing.com
BioNTech SE Sponsored ADR $BNTX Shares Purchased by CenterBook Partners LP - MarketBeat
AXQ Capital LP Acquires 1,073 Shares of Strategy Inc $MSTR - Defense World
Bank Julius Baer & Co. Ltd Zurich Lowers Stock Holdings in BioNTech SE Sponsored ADR $BNTX - Defense World
Allworth Financial LP Grows Stake in BioNTech SE Sponsored ADR $BNTX - Defense World
Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too? - Barchart.com
BioNTech Faces Strategic Crossroads as Pfizer Reduces Stake () - aktiencheck.de
Total debt per share of BioNTech SE Sponsored ADR – BER:22UA - TradingView
SG Americas Securities LLC Acquires 51,792 Shares of BioNTech SE Sponsored ADR $BNTX - MarketBeat
BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ - Finviz
BioNTech’s Earnings Call: Progress Amid Challenges - MSN
Pfizer Scales Back Major Stake in BioNTech - Ad-hoc-news.de
BioNTech Shares Under Pressure as Key Investor Exits - AD HOC NEWS
Allianz SE Buys 5,080 Shares of BioNTech SE Sponsored ADR $BNTX - Defense World
BioNTech Shares Face Pressure as Pfizer Cuts Stake () - aktiencheck.de
Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up By Reuters - Investing.com
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Is BioNTech Stock Building Momentum for a Sustained Recovery? () - aktiencheck.de
BioNTech SE (BNTX) Stock Price, Trades & News - GuruFocus
BioNTech SE Reports Q3 2025 Financial Results - MSN
BioNTech Earnings: Steady Progress in Next-Generation Oncology Pipeline; Guidance Raised - Morningstar
BioNTech Q3 2025 Earnings Call Transcript - MarketBeat
BioNTech’s Promising Clinical Study: A New Hope for Advanced Solid Tumors? - MSN
BioNTech Faces Critical Earnings Test Amid Divergent Forecasts () - aktiencheck.de
BioNTech SE’s Promising Phase 3 Study on NSCLC Treatment: A Potential Game-Changer - TipRanks
BioNTech’s BNT327: A Promising New Approach in Breast Cancer Treatment - MSN
BioNTech’s BNT116 Study: A New Hope for Advanced Lung Cancer? - MSN
BioNTech’s Promising PDAC Study: Market Implications and Progress - MSN
BioNTech’s Latest Clinical Study: A New Hope for Advanced Solid Tumors? - TipRanks
ETFs Investing in BioNTech SE Sponsored ADR Stocks - TradingView
BioNTech’s Latest Study on BNT327: A Potential Game-Changer in Lung Cancer Treatment - TipRanks
Genmab and BioNTech’s Promising Study on Metastatic Colorectal Cancer Treatment - TipRanks
Bristol-Myers Squibb and BioNTech’s New Study: A Potential Game-Changer in Cancer Treatment? - TipRanks
Bristol-Myers Squibb and BioNTech Launch New Colorectal Cancer Study - TipRanks
1.00%
2.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):